Skip to main content
Log in

Gentamicin dosing in neonatal patients

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Objective: To compare trough and peak serum gentamicin concentrations in neonatal patients using two dosing regimens.

Method: A retrospective audit of gentamicin serum concentrations obtained with the current neonatal gentamicin‐dosing regimen (regimen 1) was conducted. Results were then compared with the introduction of a new regimen (regimen 2). Preliminary results necessitated a change to a further dosage schedule (regimen 3), where data was again collected.

Results: For regimen 1,79% of patients achieved satisfactory trough concentrations, 30% achieved satisfactory peak concentrations, and 16% achieved a satisfactory combined trough and peak concentration.For regimen 2,80% of patients achieved satisfactory trough concentrations, 63% achieved satisfactory peak concentrations, and 48% achieved a satisfactory combined trough and peak concentration.For regimen 3,76% of patients achieved satisfactory trough concentrations, 56% achieved satisfactory peak concentrations, and 45% achieved a satisfactory combined trough and peak concentration.

Conclusion: Regimen 3 shows a marked improvement in serum gentamicin concentrations. However neonates in the 32‐38 weeks post‐conceptional age group achieved higher trough and peak serum gentamicin levels than expected. Therefore the dosage interval in this group of neonates will be increased from 18 hourly to 24 hourly dosing, and regimen reaudited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McCormack JP, Jewesson PJ. A critical re-evaluation of the 'therapeutic range' of aminoglycosides. Clin Infect Dis 1992;14:320-39.

    Google Scholar 

  2. Thomson AH, Way S, Bryson SM, McGovern EM, Kelmann AW. Population pharmacokinetics of gentamicin in neonates. Dev Pharmacol Ther 1988;11:173-9

    Google Scholar 

  3. Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma levels with mortality in patients with Gram negative bacteremia. J Infect Dis 1984;149:443-8

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gooding, N., Elias‐Jones, A. & Shenoy, M. Gentamicin dosing in neonatal patients. Pharm World Sci 23, 179–180 (2001). https://doi.org/10.1023/A:1012221801816

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012221801816

Navigation